Lakewood-Amedex Biotherapeutics
(NASDAQ) LABT
Lakewood-Amedex Biotherapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$3.85
EPS (TTM)
$-0.69
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$7.28
Volume
5,182,079
Open
$8.65
Price
$7.28
Volume
5,182,079
Open
$8.65
Previous Close
$7.35
Daily Range
$7.01 - $9.40
52-Week Range
$5.75 - $9.82
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$7.28
Volume
5,182,079
Open
$8.65
Previous Close
$7.35
Daily Range
$7.01 - $9.40
52-Week Range
$5.75 - $9.82
LABT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lakewood-Amedex Biotherapeutics
LABT Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
0%
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
N/A
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
5.18M
Short Interest
0.00%
Avg. Volume
137.56K
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Lakewood-Amedex Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.03
+1.0%
Gross Margin
N/A
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
5
N/A
Net Income
$0.74
+0.9%
EBITDA
$0.68
+0.8%
Quarterly Fundamentals
Net Cash
$0.24
+0.3%
Accounts Receivable
N/A
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.04
+0.3%
Short Term Debt
$1.62
+14.4%
Return on Assets
-495.77%
N/A
Return on Invested Capital
N/A
N/A
Free Cash Flow
$0.42
+0.6%
Operating Cash Flow
$0.42
+0.6%